Atrial fibrillation (AF), as the most common cardiac arrhythmia worldwide, is associated with increased mortality and morbidity. Successful therapeutic strategies have been introduced so far, but they are associated with significant costs. Therefore, identification of modifiable risk factors of AF and the development of appropriate preventive strategies may play a substantial role in promoting community health and reducing health care system costs. Modifiable cardiovascular risk factors including obesity, hypertension, diabetes mellitus, obstructive sleep apnea, alcohol consumption, smoking, and sedentary lifestyles have been proposed as possible contributors to the development and progression of AF. In this review, we discuss the role of modifiable risk factors in the development and management of AF and the evidence for the underlying mechanism for each of the potential risk factor.
INTRODUCTION
Atrial fibrillation (AF), as the most common cardiac arrhythmia worldwide, is estimated to affect almost 18 million people in Europe by 2060 [1, 2] and poses a significant burden to the healthcare systems [3, 4] . AF is associated with increased mortality and morbidities such as stroke and dementia [5] [6] [7] [8] . Successful therapeutic strategies have been introduced such as oral anticoagulation, pharmacological rate control as well as pharmacologic or electrical cardioversion, antiarrhythmic drugs and catheter ablation for rhythm control; however they are associated with significant costs [9] [10] [11] [12] [13] [14] . The increasing age of the population, and in parallel the increasing prevalence of the risk factors for development of AF, have strengthened the hypothesis of the epidemic emergence of AF in the coming decades [15] . Therefore, identification of probable modifiable risk factors of AF and the development of appropriate preventive strategies, mainly in high-risk patients, may play a substantial role in promoting community health and reducing health care system costs [1] .
Modifiable cardiovascular risk factors including obesity, hypertension (HTN), diabetes mellitus, obstructive sleep apnea (OSA), alcohol consumption, smoking, and sedentary lifestyles have been proposed as possible contributors to the development and progression of AF [7, [16] [17] [18] [19] . In contrast, the evidence for the association of some other cardiovascular risk factors such as dyslipidemia with AF is less robust [20] . In this review, we discuss the role of modifiable risk factors in the development and management of AF and the evidence for the underlying mechanism for each of the potential risk factors associated with AF.
Obesity
Multiple epidemiological studies have demonstrated a strong and independent relationship between obesity and AF in recent years [17, 21] . The Framingham Heart Study reported that each unit increase in body mass index (BMI) was associated with 4 to 5% increased risk of incident AF, independent of other comorbidities such as acute myocardial infarction, diabetes and HTN [22] . Moreover, the ARIC study reported that a BMI higher than 25 kg/m 2 (as a definition for overweight and obesity) accounted for approx. 18% of cases of incident AF [23] . A recent meta-analysis showed per 5 units increment in BMI, risk of AF increased by around 1.3 times [24] . Another metaanalysis on 587,372 subjects confirmed a higher incidence of AF in obese individuals in comparison with non-obese ones (6.3% versus 3.1%; RR (Relative Risk) = 1.51) [25] . Besides, other studies have indicated that patients with BMI ≥ 35kg/m 2 had a higher rate of post-ablation AF recurrence compared with those with BMI < 35 kg/m 2 HR (Hazard Ratio) = 1.22) [26] .
Although the association between obesity and AF appears to be confirmed, the evidence regarding the effect of weight loss on the AF outcomes is more limited. However, it seems that weight loss might be beneficial in terms of a lower AF risk through indirect ways, by its impact on blood pressure, insulin resistance, and sleep disorders [27] . Results from the LEGACY study in patients with AF showed that weight loss sustained in the long term was associated with a significant reduction of AF development. Their results indicated that more than 10% weight loss resulted in a 6-fold more chance of arrhythmia-free survival in comparison to < 9% weight loss [28] .
The association between AF and obesity seems to be multifactorial. Left atrial (LA) enlargement due to obesity is considered an important underlying precursor of AF [29] . Moreover, a slower LA conduction time, as well as shorter effective refractory periods in both LA and pulmonary veins, have been reported in patients with higher BMI [30] . Also, a higher amount of pericardial and epicardial fat tissues in obese subjects, which seem to play a significant role in promoting arrhythmogenesis due to their pro-inflammatory properties, are further possible mechanisms [31, 32] . Furthermore, obstructive sleep apnea and hypertension, which are considered to be associated with obesity, are deemed as other indirect mechanisms for obesity-induced AF [21] .
Hypertension
HTN has long been recognized as one of the major risk factors for cardiac arrhythmias, particularly AF [33] . Most of the studies investigating the association between HTN and AF reported a high prevalence rate of HTN, ranging from 50 to 90%, in patients with AF [34] . Not only HTN (systolic blood pressure (SBP) ≥ 130 mmHg), but also pre-HTN (SBP 120-129 mmHg) have been shown to increase the risk of incident AF by 2.6 and 1.8 times, respectively [28] . According to the Framingham Heart Study, both borderline SBP and stage II-IV (SBP > 160 mmHg and diastolic BP > 95 mmHg) were associated with an increased risk of AF (OR for men = 1.5 and for women = 1.4) [35] .
Interestingly, recent evidence supports the idea that optimal treatment of HTN may be effective in AF prevention; however, the best HTN treatment strategy leading to the best AF outcome is less conclusive [36] . Results of the ARREST-AF study indicated that poorer control of HTN was associated with a higher rate of AF recurrence after ablation (HR 1.3; p < 0.02) [37] . A large metaanalysis with a pooled sample size of 56,308 subjects revealed that angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) could decrease the relative risk of AF by almost one-third [38] .
Extensive LA remodeling, which contributes to the substrate for AF, is a well-established mechanism for hypertension-induced AF [39] . Left ventricular (LV) hypertrophy as well as impaired diastolic dysfunction are further pathophysiological features of chronic HTN which are related to the occurrence of AF [40] . Moreover, global conduction slowing and regionally delayed conduction, mainly in the crista terminalis have been demonstrated in patients with chronic HTN [41] .
Diabetes
The association between diabetes as well as elevated blood glucose levels and incident AF has been demonstrated in various studies [42] . In a nationwide cohort study, the youngest diabetic patients had a more than 2-fold increased AF risk, and diabetes was independently associated with developing AF [43] . Similarly, results from another study showed that diabetes type II increased the risk for new-onset AF by 1.5 fold, irrespective of other coexisting comorbidities [44] . Moreover, it has been argued that per additional year of diabetes, the estimated risk of AF could increase by 3% [45] . A recently conducted meta-analysis showed that prediabetes and diabetes increase the AF risk by 20% and 28% respectively, with a dose-response relationship between increasing blood glucose and AF [46] . In another meta-analysis, patients with diabetes showed 39% greater risk of incident AF compared with the control group [42] . However, the impact of intense glycaemic control (IGC) on the incidence and recurrence of AF is not clear yet [47] . In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, non-intense glycaemic control (HbA1c: 7.0-7.9%) was not inferior in preventing new AF in comparison with IGC (HbA1c < 6.0%) [48] .
Insulin resistance, oxidative stress, connexin remodeling, and glycaemic fluctuations, as well as autonomic, electrical, electromechanical and structural remodeling, are among the most well established pathophysiological mechanisms for diabetes-induced AF [49] . Other mechanisms such as prolonged intraatrial conduction time and diffuse interstitial fibrosis were investigated as possible triggers of increased arrhythmogenicity in diabetes in animal models [40] .
Diet
Fish and omega-3 polyunsaturated fatty acids (PUFAs) have been suggested by some studies to lower AF risk; although the results seem inconsistent [50] . A pooled analysis of two prospective studies including the Cohort of Swedish Men and the Swedish Mammography Cohort did not support a beneficial impact of PUFAs or fatty fish intake on incident AF [51] . However, a single randomized controlled trial (RCT) reported that the Mediterranean diet with olive oil may decrease AF risk by approx. 40% (HR 0.62; 95% confidence interval: 0.45-0.85) [52] .
Chocolate intake was first introduced as a protective factor for AF [53] ; however, results from a recently meta-analysis with a pooled population of 180,454 participants and 16,356 AF cases showed no significant difference in AF rate between participants with the highest chocolate intake compared with the lowest category of chocolate intake (HR = 0.95; 95% CI: 0.90-1.03) [54] . In a large population-based cohort study on 57,053 participants, coffee consumption was also shown to be associated with a lower rate of AF risk [55] .
It seems that data about the association between a specific dietary approach and AF risk is still largely lacking, and more evidence is required for drawing sound conclusions [52] .
Alcohol consumption
Acute alcohol intake is a well cause of AF, described with the term "Holiday Heart" [27] . Most observational studies have established a significant association between high levels of alcohol consumption and AF. However, the beneficial effects of mild-moderate alcohol intake is a matter of question yet [56] . According to the Framingham Heart Study, heavy alcohol intake of more than three drinks per day (> 36 g alcohol/day) was significantly associated with a greater risk of incident AF [57] . Moreover, a meta-analysis on 859,420 participants showed a linear association between alcohol intake and incident AF over 12 years of follow-up [58] . In addition, results from a recently conducted meta-analysis revealed that although low levels of alcohol intake were not associated with the AF development, moderate and high alcohol intake were associated with a heightened AF risk [27] . Underestimation of alcohol consumption may be a major limitation in the different studies, since in most of them the quantities of alcohol intake were typically self-reported by the participants. So, it seems that there might be no safe level of chronic alcohol intake regarding AF development. Nevertheless, the impact of alcohol consumption and cessation on post-ablation AF recurrence seems not clear yet. Molecular remodeling, fibrosis, electrophysiologic characteristics that favor re-entry, and lastly association of alcohol intake with the incidence of other AF risk factors have been introduced as the possible mechanism [21].
Smoking
Smoking is considered a major risk factor for AF development and has been reported as a component in several risk prediction models [59] . Smoking is not only an important parameter for identification of patients at high risk of AF, but also a factor that increases the risk of thromboembolic events following an AF diagnosis [60, 61] . Data from large cohort studies showed that both former and current smoking were equally associated with increased AF risk [62] . Also, results from a recent meta-analysis confirmed that smoking was associated with an increased risk of AF in a dosedependent manner; however, this association was weaker among former smokers compared to current smokers [63] . That meta-analysis highlighted a possible dose-dependent increase in risk; longer duration of smoking and a higher number of cigarettes per day might lead to a higher risk of AF [63] . Importantly, secondhand tobacco exposure, as well as exposure during gestational development, have also been associated with risk of AF [64, 65] . So it seems that smoking cessation should be recommended not only as a proven risk factor of many other cardiovascular disorders, but also as a risk factor for AF; however, data on post-ablation AF recurrence are still lacking. The good news is that a reduction of around 36% in AF risk has been reported in patients who were able to quit smoking [66] .
Different direct and indirect mechanisms (including increased myocardial ischemia, reduced lung function) have been evoked to explain the association between smoking and incident AF [40] . The increased volume of atrial fibrosis, as well as increased AF susceptibility caused by the duration of the action potential (APD) prolongation are two major direct mechanisms [67] .
Dyslipidemia
The role of dyslipidemia, as a significant risk factor for cardiovascular diseases, in AF is not fully understood as a result of limited evidence. Although most of the studies showed inverse associations between AF and every 10-50 mg/dL increase in total cholesterol or low-density lipoprotein (LDL), or total cholesterol ≥ 220-280 mg/dL or LDL ≥ 150 mg/dL, in some studies, this association was not significant [20] . Moreover, results for high-density lipoprotein cholesterol (HDL) and triglycerides (TG) are more heterogeneous; while some of the studies have shown inverse associations, others have revealed direct or null and/or mixed associations [20] . In a pooled dataset from the Framingham Heart Study and the Multi-ethnic Study of Atherosclerosis (MESA), there was no association between LDL levels and AF. However, higher levels of cholesterol and HDL, as well as lower levels of TG, were associated with lower risk of AF [34] . In contrast, the Kailuan Study showed an inverse association of total cholesterol, and LDL levels with incident AF after a follow-up period of 7.12 years on 88,785 participants, while no significant association was observed between TG or HDL levels and AF [61] . In another study on 28,449 individuals, low HDL was related to an increased AF risk in women (HR = 2.86), but not in men (HR = 1.35) [68] . The beneficial impact of lipid-lowering therapy in the secondary prevention of AF is a further matter of debate. Although statin therapy has been shown to be beneficial in reducing AF risk as a secondary prevention, the evidence for a role in primary prevention of AF is still insufficient [69, 70] .
Physical Activity
Recent evidence shows that a non-sedentary lifestyle activity plays a protective factor with regard to AF occurrence; however, extreme and prolonged exercise itself can be considered a risk factor for AF [71, 72] . In the majority of population-based studies, mild to moderate physical activity was associated with a decreased AF risk, whereas only few studies failed to show an association between exercise and AF [73, 74] . It has been suggested that daily walking or cycling might lead to a risk reduction of AF by about 20% [75] . In the Cardiovascular Health Study, the incidence of AF in older individuals with more regular physical activity was reported to be around 50% lower than those with less activity [76] . Moreover, results from two Asian studies showed that moderate physical activity was a protective factor for AF [77, 78] .
A recent meta-analysis indicated a J-shaped pattern for the association between risk of AF and extent of exercise [79] . Other studies also reported that athletes are about two to five times more likely to have AF than the non-athletes [80] . Thus, according to the available evidence, it seems that the level of physical activity and risk of AF have a nonlinear relationship. Both sedentary lifestyle and very extreme exercise appear to be possible triggers for AF development, mainly in young men. However, the effect of different types of sports, as well as their durations and frequencies on AF is a matter of question yet.
Although no precise mechanism for the increased AF risk among athletes with severe physical activity has been identified yet, some important pathways for the underlying pathophysiology have been proposed. Elevated autonomic activity, atrial dilatation, and fibrosis, abrupt shifts between vagal dominance and sympathetic drive are among the suggested mechanisms for increasing the risk of AF following endurance sports [81, 82] . In contrast, improving systolic and diastolic function, lowering sympathetic drive, as well as reducing arterial stiffness are the proposed mechanisms for the beneficial effects of physical activity on AF risk reduction [83, 84] .
Sleep disorders
In most of the conducted studies, a significant association has been observed between sleep disorders and AF risk (RR range of 1.26-2.51) [85] . A recent meta-analysis reported that sleep disorders increased the risk of AF significantly (RR = 1.70), and higher severity of sleep disorders was associated with a higher AF risk [86] . Moreover, another meta-analysis confirmed that the risk of AF was greater among patients with sleep disorders compared with the control group OR (Olds ratio) = 2.1 [87] . Further studies highlighted that different types of sleep disorders might have different impacts on the AF incidence [88] . In a large multiethnic study on 2048 participants, AF was more frequent in patients with poorer sleep quality [89] . Interestingly, ethnicity was recently introduced as an important factor in the association between sleep disorders and AF with a higher risk of AF in black individuals with sleep disorders [90] .
A role of sleep disorders in the development of post-ablation AF recurrence has also been indicated in a recent meta-analysis [91] . The beneficial effect of continuous positive airway pressure device (CPAP) treatment has also been demonstrated in reducing the rate of AF recurrence after ablation [91] . However, the efficacy of any therapeutic intervention for patients with sleep disorders in decreasing the new-onset AF risk is not well understood. Multiple factors have been introduced as possible pathophysiologic mechanisms of sleep disorders-induced AF, including hypercapnic hypoxia, changes in intrathoracic pressure increased ganglionated plexi activity, structural and electrical remodeling, and reduced atrial effective refractory period (ERP) [92, 93] . 
CONCLUSIONS
It seems that most of the suggested modifiable risk factors of AF including obesity, hypertension, diabetes, smoking, and the beneficial effects of their primary and secondary preventions are common with cardiovascular diseases risk factors. However, the evidence for the efficacy of optimal control of these risk factors by dyslipidemia management, glycaemic control, optimal antihypertensive treatment, physical activity, and alcohol cessation in improving AF outcomes is less evident. Similarly, although a higher prevalence of AF in patients with sleep disorders seems undeniable, the efficacy of therapeutic interventions for decreasing the risk of new-onset AF is not clear yet. Nevertheless, avoiding a sedentary lifestyle or vigorous exercise may contribute to prevention of AF onset, especially in young men. Considering the association between obesity and other AF risk factors such as HTN, diabetes, and sleep disorders, weight loss appears to play a significant role in the prevention of new and recurrent AF. 
